Biologics

ab-sciex-extends-the-applicability-of-selexion-technology-swath-acquisition-and-proteinpilot-software-for-systems-biology-research

Ab Sciex launches MS solutions for advanced research

  • US
  • |
  • News

Singapore: Ab Sciex, a global leader in analytical technologies, has unveiled three new solutions for biological researchers to improve identification and quantitation of proteins, peptides, metabolites and lipids. The company extended... Read more

ge-healthcare-launches-biacore-t200-software-v

GE launches new software for molecular screening


  • US
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: GE Healthcare has launched Biacore T200 Software v.2.0, offering researchers a flexible and powerful tool for... Read more

amgen-and-astellas-pharma-enter-a-strategic-alliance-to-develop-and-commercialize-five-amgen-pipeline-medicines-in-japan

Amgen & Astellas form JV, will co-develop biologics...


  • Japan
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: US-based Amgen and Japanese firm Astellas Pharma have entered into a strategic alliance to co-develop and co-commercialize... Read more

facility-astellas

WuXi opens first cGMP biologics facility in China

  • China
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: WuXi AppTec has invested substantially in building its capabilities and capacity in biologics in the past few years. The current... Read more

tap-biosystems-to-market-automated-systems-in-australia-and-new-zealand

Aus, NZ get automated culture systems from TAP

Singapore: UK-based TAP Biosystems has appointed Australia's TrendBio, a company that supplies high quality life science research products,... Read more

dr-villoo-morabhai-patell

Asia's challenge: Meeting US, EU requirements

  • India
  • |
  • Opinion
  • |
  • By Dr Villoo Morawala-Patell
  • |
  • 0 Comment

One of the biggest challenges in developing and manufacturing antibodies is proving the equivalence or similarity to the reference product.... Read more

industry-award-collaboration

BAC, GE Healthcare collaboration wins industry award

  • Europe
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: BAC's partnership with GE Healthcare to develop innovative purification media for the production of novel types of biopharmaceuticals... Read more

antibodies-market-growth

Monoclonal antibodies market set to grow in Europe

  • Europe
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Efficient resource to therapy of complex disorders with lesser side-effects has accelerated growth of monoclonal antibodies based... Read more

ab-sciex-libraryview-software-couples-with-qtrap-and-tripletof-technologies-to-enable-efficient-identification-of-contaminants

AB SCIEX LibraryView software to screen contaminants

  • US
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: AB SCIEX launched a new application called LibraryView Software that enables faster and more reliable identification of contaminants... Read more

ayoxxa-biosystems-gets-usd3

Biochips firm AyoxxA gets $3.37 million funding

  • Singapore
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: AyoxxA Biosystems, an international biotechnology company, has closed a $3.37 million (2.6 million Euro) series A financing round.... Read more

merck-millipore-to-develop-new-ways-to-harvest-stem-cell-from-bioreactor-based-cultures

Merck to develop processes for stem cell cultures

  • Europe
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Merck Millipore, the life science division of Merck, and the Institute of Bioprocess Engineering and Pharmaceutical Technology,... Read more

bad-news-for-super-bugs-new-venture-by-ampliphi-and-sph-will-combat-the-growing-threat-of-antibiotic-resistance

AmpliPhi, SPH to combat antibiotic-resistant super bugs

  • Australia
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Australia-based AmpliPhi Biosciences is looking to acquire Brookvale, a Sydney-based Special Phage Services (SPS). The combination... Read more

Special Features

Survey Box

Ranbaxy Controversy

Will the Ranbaxy controversy end the Indian pharma dominion in the US market?

Send this article by email

X